Please login to the form below
briefing
This page shows the latest briefing news and features for those working in and with pharma, biotech and healthcare.
FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
Briefing documents published earlier this week raised questions over the safety profile of roxadustat. ... The CRDAC outcome is not surprising, after briefing documents published ahead of the committee meeting earlier this week raised questions over the
Latest news
-
FDA questions safety profile of AZ, FibroGen’s anaemia drug roxadustat
In briefing documents published ahead of a meeting of the Cardiovacular and Renal Drugs Advisory Committee meeting on 15 July, the FDA said that “roxadustat’s efficacy is not in question”. ... The briefing documents included details from a pooled
-
Biogen to begin shipping newly approved Alzheimer’s treatment in two weeks
Although previous FDA briefing documents backed aducanumab – which now has the new brand name Aduhelm – the regulatory agency’s Peripheral and Central Nervous System Drugs Advisory Committee overwhelmingly voted no on
-
FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
Although previous FDA briefing documents backed aducanumab – which now has the new brand name Aduhelm – the regulatory agency’s Peripheral and Central Nervous System Drugs Advisory Committee overwhelmingly voted no on
-
WHO director-general says pandemic can be brought under control within months
news briefing yesterday. ... In the news briefing, Ghebreyesus added that the WHO has expressed its interest in establishing a ‘COVID-19 technology transfer hub’ for mRNA vaccines, in a bid to bolster production of
-
J&J’s one-dose COVID-19 vaccine granted emergency use approval by FDA
Last week, briefing documents published ahead of the VRBPAC meeting endorsed the safety and efficacy of J&J’s vaccine and reiterated its efficacy of 66.1% in a phase 3
FDA questions safety profile of AZ, FibroGen’s anaemia drug roxadustat
Biogen to begin shipping newly approved Alzheimer’s treatment in two weeks
FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
WHO director-general says pandemic can be brought under control within months
J&J’s one-dose COVID-19 vaccine granted emergency use approval by FDA
More from news
Approximately 1 fully matching, plus 142 partially matching documents found.
Latest Intelligence
-
Your clinical trial participants are precious, so treat them as such
So treating patients as partners is not just a retention or financial imperative; it is a core principle that should inform all stages from clinical trial design, site staff briefing, patient
-
Mapping the patient journey: eight ways to improve support programmes
But challenges still remain. An NHS Confederation briefing in November 2018 noted the value of PSPs but cited lack of awareness among HCPs and patients as a common barrier to their
-
Awards or not, what really matters is... can you make it mean something?
Well, it runs through everything we do, from insights, strategy and briefing to critiquing creative concepts, craft in execution, channel and media selection.
-
The importance of pharma intelligence in setting brand strategy
Teams are provided in advance with a briefing package that includes the completive landscape, competitor asset profiles and TPP.
-
Industry needs an aligned position on the future of the EU OMP Regulation
The briefing questions the impact of the 1bn the EU has invested into rare disease research in the past decade.
Your clinical trial participants are precious, so treat them as such
Mapping the patient journey: eight ways to improve support programmes
Awards or not, what really matters is... can you make it mean something?
The importance of pharma intelligence in setting brand strategy
Industry needs an aligned position on the future of the EU OMP Regulation
More from intelligence
Approximately 1 fully matching, plus 27 partially matching documents found.
Latest appointments
-
mXm Group bolsters its editorial and account handing teams
Chris Watson joins the agency as its editorial manager after previously holding a number of senior editorial and medical writing positions at Springer Healthcare, Touch Briefings, Mudskipper and Elsevier.
-
JPA strengthens PR offering
He will work on briefing and strategy documents, event organisation and media outreach.
mXm Group bolsters its editorial and account handing teams
JPA strengthens PR offering
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Out Of Office: The New Normal for Ad Agencies
We have even worked with creatives on the other side of the world, briefing a job overnight to find it magically completed the next morning, like the elves and the shoemaker.
-
Is communication killing the COVID-19 vaccine’s chance at success?
Press briefings and public advice in the UK has felt impossible to follow at times.
-
Living with psoriasis: a patient perspective
We recently spoke to Alex to get a first hand account of living with psoriasis here in the UK. “My psoriasis flares up about once a month, which leaves me looking like I have third-degree burns on my face, legs, and stomach. Most of my friends
-
Great creative is effective creative. And effective creative is affective creative
you’ve even finished the verbal briefing.
-
Three steps I take for stress-free, successful virtual meetings and events
2. PREPARE, PREPARE, PREPARE. Briefing the Chair and speakers properly is important and is possible via several different tools, such as meeting flow documents, which are reviewed in advance of the
Living with psoriasis: a patient perspective
More from PMHub
Approximately 0 fully matching, plus 21 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Digital account director
-
Competitive
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Digital project manager
-
Competitive
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
-
Digital strategist
-
Competitive
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- GSK reveals plans for £400m R&D facility expansion in England
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- Onyx Health Launch Creative Studio After Record Year
- BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform
- Tyson Fury takes on his Invisible Opponent in hard hitting ad for suicide prevention charity Campaign Against Living Miserably
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Novo Nordisk signs deal for Prothena's heart drug worth up to $1.2bn
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
PMHub
TRIDUCIVE
Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
